Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone in post-groin hernia repair pain
NCT01992146Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Nov 2015
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of naloxone in Central sensitization (CS), sponsored by Rigshospitalet. Started Nov 2015; status: completed.
02
Drugs
naloxone
03
Conditions
Central sensitization (CS)
Beyond the preview
Go deeper on NCT01992146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01992146.